-
Company Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Xeris Pharmaceuticals
Company Profile
Quarter (USD) | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 63.60 mm | 63.60 mm | 63.60 mm | 63.60 mm | 63.60 mm | 63.60 mm |
Cash burn (monthly) | 1.00 mm | 3.24 mm | 8.60 mm | 6.30 mm | 6.67 mm | 5.99 mm |
Cash used (since last report) | 43.09 mm | 139.34 mm | 369.81 mm | 271.09 mm | 287.13 mm | 257.53 mm |
Cash remaining | 20.50 mm | -75.74 mm | -306.21 mm | -207.49 mm | -223.53 mm | -193.93 mm |
Runway (months of cash) | 20.5 | -23.4 | -35.6 | -32.9 | -33.5 | -32.4 |
13F holders | Current |
---|---|
Total holders | 143 |
Opened positions | 24 |
Closed positions | 18 |
Increased positions | 46 |
Reduced positions | 34 |
13F shares | Current |
---|---|
Total value | 174.65 bn |
Total shares | 72.96 mm |
Total puts | 45.70 k |
Total calls | 148.20 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 10.73 mm | $30.59 bn |
Vanguard | 7.77 mm | $22.13 bn |
Flynn James E | 5.88 mm | $17.24 mm |
Caxton | 5.11 mm | $14.57 bn |
CenterBook Partners | 3.48 mm | $9.92 bn |
Geode Capital Management | 3.33 mm | $9.50 bn |
Sessa Capital | 3.26 mm | $0.00 |
STT State Street | 3.20 mm | $9.13 bn |
Rosalind Advisors | 3.10 mm | $8.85 bn |
MS Morgan Stanley | 2.35 mm | $6.71 bn |